Total Mesorectal Excision with Coloanal Anastomosis: Laparoscopic Technique



Total Mesorectal Excision with Coloanal Anastomosis: Laparoscopic Technique


John H Marks

Elsa B. Valsdottir







PATIENT HISTORY AND PHYSICAL FINDINGS



  • Careful patient selection is crucial for successful sphincter preservation in rectal cancer. A detailed history and physical examination are mandatory. Contraindications include inability to receive neoadjuvant chemoradiation therapy for distal rectal cancers, either because of comorbidities or previous radiation to the pelvis, previous radical surgery on rectum, distance of tumor from the dentate line, invasion of tumor into the sphincter muscles after completion of neoadjuvant chemoradiation therapy, and fecal incontinence on presentation.


  • Detailed past medical history is obtained, emphasizing fecal continence, bowel habits, personal and family history of cancers and current medications and allergies, previous radiation to the pelvis, and previous abdominal surgeries.


  • Prior radiation therapy for other cancers in the pelvis, such as cervical or prostate, is usually a contraindication. It is, however, helpful to review the previous records with regard to the dose and field treated and make decisions on individual basis.


  • A detailed family history of cancers can help identify increased risk for other types of cancer as well as identify family members who are at an increased colon cancer risk. Recommendations should be given to first-degree relatives with regard to screening.


  • Patient age, nodal status, or tumor size are not contraindications for sphincter preservation as long as the patient is a reasonable surgical candidate and negative margins (distally and circumferentially) can be obtained.


  • Physical examination must include a thorough abdominal exam, including palpation of inguinal lymph nodes bilaterally. Most importantly, a careful digital rectal exam and a rectoscopy or flexible sigmoidoscopy are performed.


  • The location of the tumor (anterior, posterior, or lateral), distance from the anorectal ring, size, fixity, circumference, configuration, and ulceration of the tumor need to be documented. This is imperative in preoperative planning as well as allowing for assessment of response to neoadjuvant treatment later (FIG 1).


IMAGING AND OTHER DIAGNOSTIC STUDIES



  • All patients require preoperative staging of the disease with regard to the tumor, lymph node status, and distant spread, both clinically and radiographically.


  • The most accurate way to determine size, length, and depth of the tumor invasion as well as any enlarged lymph nodes is with magnetic resonance imaging (MRI) or endoscopic rectal ultrasound (ERUS) (FIG 2).


  • A computed tomography (CT) of the abdomen and chest should be obtained to evaluate for distant spread of the disease to the liver or lungs.


  • Preoperative blood work should include a hemogram, blood chemistries, and a carcinoembryonic antigen (CEA) level.


  • Full colonoscopy is needed to evaluate the entire colon for other pathology and synchronous malignant lesions or polyps.


  • Histologic assessment with biopsy of the primary tumor is necessary and usually obtained at the time of colonoscopy.






FIG 1 • Rectal cancer before (left) and after (right) neoadjuvant chemoradiation. This patient had a good response to treatment.







FIG 2 • Pre-neoadjuvant treatment MRI of a rectal cancer suitable for TATA.


SURGICAL MANAGEMENT


Preoperative Planning



  • Neoadjuvant chemoradiotherapy is the key to successful sphincter preservation. The radiation therapy is a high-dose, long-term treatment to maximize tumor downstaging. Preferred radiation dose is 5,580 cGy, with 4,500 cGy to the entire pelvis with a boost to the presacral area and tumor location, delivered over the course of 5 weeks. Concurrent chemotherapy based on 5-fluorouracil (5-FU) either orally or intravenously increases the sensitivity of the tissues to radiation, enhancing efficacy (FIG 3).


  • Neoadjuvant chemoradiation apoptotic effect occurs only at cell division. Maximum cytotoxic effect is 8 to 12 weeks after completion of treatment. Extending the interval between completion of radiation therapy and surgery up to 8 to 12 weeks therefore gives the patient the fullest benefit of the treatment, maximizing downstaging and extending the options for sphincter preservation.


  • Decision regarding sphincter preservation should be based on the status of the cancer after completion of chemoradiotherapy. All patients, except those whose cancers remain fixed at or below the 3-cm level are offered sphincter preservation.


  • Accepting a distal margin of resection from the cancer as small as 5 mm is necessary for very low tumors. This does not adversely affect outcome. Dissection is started transanally to assure a known distal margin. This is particularly helpful in the postirradiated rectal cancer where there is often only a small scar left, making decisions as to where a stapler would be placed from above difficult.


  • The patient should receive a bowel preparation the day before surgery.


  • Perioperative antibiotics and deep vein thrombosis prophylaxis should be given.


Positioning



  • The operation has both an abdominal part and perineal part. The surgeon and first assistant stand between the legs during the perineal part. For the abdominal part, which is performed laparoscopically, they stand at the patient’s right side. It is important that the surgical team is free to move around the patient. The laparoscopic equipment and energy sources are positioned to patient’s left (FIG 4).


  • The patient is placed in the lithotomy position with the buttocks extending 2 cm over the padded table edge. Both arms are padded and tucked. The chest is taped to the table to further prevent slipping of the patient as the table is maneuvered. The Foley catheter is taped over the right thigh. The abdomen is prepped with Betadine and the perineum with povidone-iodine. In women, the vagina is prepped with povidone-iodine.






FIG 3 • Author’s treatment algorithm for low rectal cancers (distal 3 cm of the true rectum). cGy, centiGray; 5-FU, 5-fluorouracil; CVI, continuous venous infusion; CATS, combined abdominal trans-sacral rectal resection; LAR, low anterior resection; TATA, transanal transabdominal rectal resection; FTLE, full-thickness local excision.







FIG 4A,B. Operating room setup.